CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 75 enrolled
Drug / intervention
Deterra Drug Deactivation Systemdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03285061
NCT03285061N/ACompleted
CompareCT.gov

Excess Opioid Disposal Following Orthopedic Foot and Ankle Surgery

Brigham and Women's Hospital·interventional·Posted Sep 15, 2017·Updated Jan 6, 2021

In Brief

A clinical study evaluating Deterra Drug Deactivation System for Medication Disposal and Behavior. Completed, enrolled 75 participants across 1 site.

Detailed Summary

This study aims to survey the drug disposal methods of orthopedic foot and ankle patients with excess pain medication following and operation. The study is a randomized control trial comparing the use of FDA approved at home disposal methods to current clinical methods of recommending disposal at medication drop off locations.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsMedication Disposal, Behavior
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
201820192020202120222023202420252026
First PostedSep 15, 2017
Enrollment StartOct 1, 2017
Primary CompletionJul 1, 2019
TodayJul 2, 2026
Enrollment to primary: 1.8 yearsPosted 8.8 years ago

Interventions

Deterra Drug Deactivation Systemdevice

A portable bag that will neutralize and dissolve excess medication, rendering it completely unusable and safe for landfill disposal. The system meets FDA and DEA standards for at home disposal systems.